The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Gewirtz, G. R.
* Articles by Gorman, J. M.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Gewirtz, G. R.
* Articles by Gorman, J. M.

Am J Psychiatry 1988; 145:1012-1014
Copyright © 1988 by American Psychiatric Association


REGULAR ARTICLES

Occult thyroid dysfunction in patients with refractory depression

GR Gewirtz, D Malaspina, JA Hatterer, S Feureisen, D Klein and JM Gorman
Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY.

Assessment of metabolic rate was useful in evaluating refractory depression in six of 15 women. Five of the six had normal levels of T3 and T4; however, each had an elevated thyrotropin-stimulating hormone level or a low metabolic rate. The depressions responded to medication with thyroid hormone.


This article has been cited by other articles:


Home page
J PsychopharmacolHome page
K. A. Gendall, P. R. Joyce, R. T. Mulder, and S. E. Luty
Thyroid Indices and Response to Fluoxetine and Nortriptyline in Major Depression
J Psychopharmacol, December 1, 2003; 17(4): 431 - 437.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
A. L. Malizia and P. K. Bridges
The management of treatment-resistant affective disorder: clinical perspectives
J Psychopharmacol, January 1, 1992; 6(2): 145 - 155.
[PDF]


Home page
J PsychopharmacolHome page
M. H. Rosenzweig and J. D. Amsterdam
Treatment-resistant depression: additional perspectives
J Psychopharmacol, January 1, 1992; 6(2): 167 - 171.
[Abstract] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1988 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org